LSM4 and hepatocellular carcinoma: Summarily, the current evidence indicated that LSM4 might act as a cancer-promoting factor and participate in the occurrence and malignant progression of HCC, and it has the potential as the diagnostic biomarker of HCC and the predictor of poor prognosis.